R&D for long COVID is collapsing | Rowan Walrath

20 septembre 2024
Much of the hesitancy to make new medicines stems from the evasive nature of long COVID itself. The condition is multisystemic, affecting the brain, heart, endocrine network, immune system, reproductive organs, and gastrointestinal tract. While researchers are finding increasing evidence for (...)
 Site référencé:  Rezo.net